Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration.

Ebbs, A

Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. [electronic resource] - Transplantation proceedings Aug 2002 - 1378-81 p. digital

Publication Type: Journal Article

0041-1345

10.1016/s0041-1345(02)02894-4 doi


Animals
CD4-Positive T-Lymphocytes--immunology
CD8-Positive T-Lymphocytes--immunology
Cyclosporine--therapeutic use
Drug Therapy, Combination
Graft Rejection--prevention & control
Granzymes
Heart Transplantation--immunology
Immunosuppressive Agents--therapeutic use
Interleukin-10--antagonists & inhibitors
Membrane Glycoproteins--analysis
Perforin
Pore Forming Cytotoxic Proteins
Rats
Rats, Inbred BN
Rats, Inbred Lew
Serine Endopeptidases--analysis
Tacrolimus--therapeutic use
Transplantation, Homologous--immunology
Transplantation, Isogeneic--immunology